AMRX - Amneal Pharmaceuticals Inc. (AMRX) CEO Chintu Patel on Q3 2020 Results - Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2020 Earnings Conference Call November 06, 2020 08:30 AM ET Company Participants Tasos Konidaris - Chief Financial Officer Chirag Patel - Co-Chief Executive Officer Chintu Patel - Co-Chief Executive Officer Conference Call Participants David Amsellem - Piper Sandler Gary Nachman - BMO Capital Markets Greg Gilbert - Truist Securities Ami Fadia - Leerink Randall Stanicky - RBC Capital Markets Dana Flanders - Guggenheim Nathan Rich - Goldman Sachs Balaji Prasad - Barclays Presentation Operator: Good morning and welcome to the Amneal Third Quarter 2020 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Amneal's Chief Financial Officer, Tasos Konidaris. Please go ahead. Tasos Konidaris Thank you, Andrew. Good morning and thank you for
For further details see:
Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2020 Results - Earnings Call Transcript